Peter Marstrand

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction

Peter Marstrand, Larry Han, Sharlene M. Day et al. · Circulation · 2020 · 212 citations · Full text

Medicine, Cardiology, Internal Medicine +7

Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

Mikhail Kosiborod, Subodh Verma, Barry A. Borlaug et al. · Circulation · 2023 · 92 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +16

Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy

Victor Nauffal, Peter Marstrand, Larry Han et al. · European Heart Journal · 2021 · 62 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +13

Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality

Peter Weeke, Jesper Sloth Kellemann, Camilla Jespersen et al. · European Heart Journal · 2019 · 35 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry

Sarah Abou Alaiwi, Thomas M. Roston, Peter Marstrand et al. · Circulation · 2023 · 20 citations · Full text

Medicine, Cardiology, Pediatrics +5